Meeder Asset Management’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9K | Buy |
143
+64
| +81% | +$4.61K | ﹤0.01% | 679 |
|
|
2025
Q4 | $5.04K | Buy |
+79
| New | +$4.87K | ﹤0.01% | 791 |
|
|
2025
Q2 | – | Sell |
-51
| Closed | -$4.49K | – | 896 |
|
|
2025
Q1 | $4.49K | Sell |
51
-39
| -43% | -$3.68K | ﹤0.01% | 784 |
|
|
2024
Q4 | $8.22K | Sell |
90
-5
| -5% | -$513 | ﹤0.01% | 747 |
|
|
2024
Q3 | $10.6K | Buy |
95
+3
| +3% | +$300 | ﹤0.01% | 602 |
|
|
2024
Q2 | $9.01K | Sell |
92
-2,967
| -97% | -$294K | ﹤0.01% | 670 |
|
|
2024
Q1 | $307K | Buy |
3,059
+695
| +29% | +$61.1K | 0.02% | 258 |
|
|
2023
Q4 | $212K | Hold |
2,364
| – | – | 0.02% | 295 |
|
|
2023
Q3 | $181K | Hold |
2,364
| – | – | 0.01% | 306 |
|
|
2023
Q2 | $198K | Hold |
2,364
| – | – | 0.01% | 313 |
|
|
2023
Q1 | $199K | Sell |
2,364
-74
| -3% | -$6.36K | 0.02% | 323 |
|
|
2022
Q4 | $199K | Sell |
2,438
-2,251
| -48% | -$181K | 0.02% | 402 |
|
|
2022
Q3 | $334K | Sell |
4,689
-115
| -2% | -$10.3K | 0.02% | 461 |
|
|
2022
Q2 | $431K | Buy |
4,804
+8
| +0.2% | +$828 | 0.03% | 424 |
|
|
2022
Q1 | $538K | Buy |
+4,796
| New | +$562K | 0.03% | 386 |
|
|
2021
Q4 | – | Sell |
-2,395
| Closed | -$241K | – | 1517 |
|
|
2021
Q3 | $241K | Sell |
2,395
-2,594
| -52% | -$286K | 0.01% | 667 |
|
|
2021
Q2 | $582K | Sell |
4,989
-18,201
| -78% | -$2.19M | 0.03% | 434 |
|
|
2021
Q1 | $2.55M | Buy |
23,190
+19,784
| +581% | +$2.15M | 0.13% | 151 |
|
|
2020
Q4 | $342K | Sell |
3,406
-27,842
| -89% | -$2.58M | 0.08% | 216 |
|
|
2020
Q3 | $2.44M | Buy |
31,248
+9,235
| +42% | +$696K | 0.16% | 114 |
|
|
2020
Q2 | $1.53M | Sell |
22,013
-6,659
| -23% | -$420K | 0.1% | 181 |
|
|
2020
Q1 | $1.34M | Buy |
28,672
+18,795
| +190% | +$1.21M | 0.1% | 162 |
|
|
2019
Q4 | $783K | Sell |
9,877
-27,105
| -73% | -$2.08M | 0.05% | 300 |
|
|
2019
Q3 | $2.73M | Buy |
36,982
+31,622
| +590% | +$2.27M | 0.18% | 112 |
|
|
2019
Q2 | $417K | Sell |
5,360
-99
| -2% | -$7.52K | 0.03% | 440 |
|
|
2019
Q1 | $414K | Buy |
5,459
+65
| +1% | +$5.17K | 0.03% | 410 |
|
|
2018
Q4 | $394K | Sell |
5,394
-13,457
| -71% | -$1.07M | 0.04% | 368 |
|
|
2018
Q3 | $1.8M | Sell |
18,851
-26,804
| -59% | -$2.66M | 0.14% | 148 |
|
|
2018
Q2 | $4.56M | Buy |
45,655
+14,472
| +46% | +$1.53M | 0.39% | 74 |
|
|
2018
Q1 | $3.29M | Buy |
31,183
+7,648
| +32% | +$773K | 0.31% | 85 |
|
|
2017
Q4 | $2.18M | Sell |
23,535
-17,230
| -42% | -$1.57M | 0.19% | 120 |
|
|
2017
Q3 | $3.69M | Buy |
40,765
+31,105
| +322% | +$2.65M | 0.4% | 65 |
|
|
2017
Q2 | $812K | Sell |
9,660
-5,953
| -38% | -$480K | 0.08% | 257 |
|
|
2017
Q1 | $1.26M | Buy |
15,613
+12,235
| +362% | +$962K | 0.11% | 180 |
|
|
2016
Q4 | $254K | Buy |
3,378
+1,263
| +60% | +$91.2K | 0.02% | 461 |
|
|
2016
Q3 | $143K | Sell |
2,115
-1,304
| -38% | -$87.5K | 0.01% | 570 |
|
|
2016
Q2 | $232K | Buy |
3,419
+800
| +31% | +$58.8K | 0.02% | 548 |
|
|
2016
Q1 | $189K | Buy |
+2,619
| New | +$172K | 0.02% | 582 |
|
Other funds holding EMN
VPM
VCM
Meeder Asset Management's EMN Position: Q1 2026 in Review
Meeder Asset Management increased its Eastman Chemical (EMN) stake by 81% in Q1 2026, buying an estimated $4.61K and bringing the position to 143 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #679.
Meeder Asset Management first reported a position in EMN in Q1 2016 and has held it in 38 quarters since. The position peaked at $4.56M in Q2 2018. 635 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Meeder Asset Management held 143 shares of Eastman Chemical worth $10.9K as of Q1 2026.
- Meeder Asset Management bought 64 Eastman Chemical shares in Q1 2026, an estimated $4.61K.
- Eastman Chemical made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #679 holding.
- Meeder Asset Management first reported a position in Eastman Chemical in Q1 2016 and has held it in 38 quarters since.
- Meeder Asset Management's Eastman Chemical position peaked at $4.56M in Q2 2018.
- 635 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.